MedTrace Logo

Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)

NCT03000777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-08-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of oral melatonin plus zinc supplementation in relieving self-reported fatigue in CFS/ME

Conditions

  • Fatigue Syndrome, Chronic
  • Myalgic Encephalomyelitis

Interventions

DIETARY_SUPPLEMENT

melatonin plus zinc

Melatonin 1 mg plus Zinc 10 mg o.d. 1 hour before going to bed during 16 weeks

OTHER

Placebo

Isomaltose o.d. 1 hour before going to bed during 16 weeks

Sponsors & Collaborators

  • Hospital Vall d'Hebron

    collaborator OTHER

  • Laboratorio Echevarne

    collaborator INDUSTRY

  • Laboratorios Viñas, S.A.

    lead INDUSTRY

Principal Investigators

  • José Alegre, MD; PhD · Vall d'Hebron University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-07-31
Completion
2017-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000777 on ClinicalTrials.gov